Kidswell BioKidswell Bio Corporation4584東証グロース医薬品FY ending Mar 2026, consolidated, J-GAAP

Kidswell Bio FY ending Mar 2020 results

Kidswell Bio brought in ¥1.08B in revenue.

It lost about ¥108 for every ¥100 of sales at the operating level.

Where the money goes

Where ¥100 of sales goes

For every ¥100 Kidswell Bio sells, how much goes where, and how much is kept.

FY ending Mar 2020
Cost of sales
¥61
SG&A
¥147
Operating loss
¥108
Net loss
¥679

Margin funnel (derived from reported values)Gross margin 39.4% → Operating margin -107.8% → Net margin -678.9%

Sources

Show source documents (2)
  • EDINET (FSA Japan)

    有価証券報告書-第22期(令和3年4月1日-令和4年3月31日)

    ID S100OITB2022-06-28Open
  • EDINET (FSA Japan)

    有価証券報告書-第21期(令和2年4月1日-令和3年3月31日)

    ID S100LVK52021-06-30Open

Extracted from XBRL: 40 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.